Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry

Objective: The corner stone of atrial fibrillation therapy includes the prevention of stroke with less adverse effects. The Global AnticoagulantRegistry in the FIELD–Atrial Fibrillation (GARFIELD-AF) study provided data to compare treatment strategies in Turkey with other populations andevery-day practice of stroke prevention management with complications.Methods: GARFIELD-AF is a large-scale registry that enrolled 52,014 patients in five sequential cohorts at >1.000 centers in 35 countries. Thisstudy was initiated to track the evolution of global anticoagulation practice, and to study the impact of NOAC therapy in AF. A total of 756 patientsfrom 17 enrolling sites in Turkey were in cohort 4 and 5. Treatment strategies at diagnosis initiated by CHA2DS2-VASc score, baseline characteristics of patients, treatment according to stroke and bleeding risk profiles, and INR values were analyzed in cohorts. Additionally, event ratesduring the first year follow up were evaluated.Results: AF patients in Turkey were mostly seen in young women. Stroke risk according to the CHADS2 score and CHA2DS2-VASc score compared with world data. The mean of risk score values, including HAS-BLED score were lower in Turkey than in the world data. The percentageof patients receiving FXa inhibitor with or without an antiplatelet usage was more than the other drug groups. All-cause mortality was higher inTurkey. Different form world data when HAS-BLED score was above 3, the therapy was mostly changed to antiplatelet drugs in Turkey.Conclusion: In addition to deficiencies in available treatment options, patient care and clinical outcomes of patients with AF, the data of GARFIELD-AF provide data from Turkey about therapeutic strategies and best practices. (Anatol J Cardiol 2019; 21: 272-80)

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-72.
3. Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 1996; 27: 1765-9.
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
5. Stępińska J, Kremis E, Konopka A, Wożakowska-Kapłon B, Ruszkowski P, Kukla P, et al. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry. Kardiol Pol 2016; 74: 362-71.
6. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J 2012; 163: 13-9e1.
7. Yavuz B, Ata N, Oto E, Katircioglu-Öztürk D, Aytemir K, Evranos B, et al. Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort. Europace 2017; 19: 734-40.
8. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al.; GARFIELD Registry Investigators. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One 2013; 8: e63479.
9. Fox KAA, Gersh BJ, Traore S, Camm AJ, Kayani G, Krogh A, et al.; for the GARFIELD-AF Investigators. Evolving quality standards for large-scale registries: the GARFIELD-AF experience. Eur Heart J - Quality of Care and Clinical Outcomes 2017; 3: 114-22.
10. Ertas F, Eren NK, Kaya H, Aribas A, Acar G, Kanadasi M, et al.; AFTER Investigators. Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER). Cardiol J 2013; 20: 447-52.
11. Altay S, Yıldırımtürk Ö, Çakmak HA, Aşkın L, Sinan ÜY, Beşli F, et al.; NOAC-TURK Study Collaborators. New oral anticoagulantsTURKey (NOAC-TURK): Multicenter cross-sectional study. Anatol J Cardiol 2017; 17: 353-61.
12. Başaran Ö, Beton O, Doğan V, Tekinalp M, Aykan AÇ, Kalaycıoğlu E, et al.; RAMSES Study. ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study). Anatol J Cardiol 2016; 16: 734-41.
13. Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, et al.; GLORIA-AF Investigators. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. Am J Med 2015; 128: 1306-13.e1.
14. Steinberg BA, Kim S, Fonarow GC, Thomas L, Ansell J, Kowey PR, et al. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 2014; 167: 735-42.e2.
15. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11: 423-34.
16. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006; 27: 3018-2.
17. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al.; BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
18. Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, et al.; GARFIELD-AF Investigators. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELDAF registry: rationale for comprehensive management of atrial fibrillation. PLoS One 2018; 13: e0191592.

APA	YETİŞ SAYIN B, OKUTUCU S, YILMAZ M, ÖZDEMİR K, AYDINLAR A, ŞAHİN D, ALTUN A, AÇIKEL S, OKUYAN E, Sucu M, ÖNGEN Z, Ersanli M, YILMAZ Ö, Demir M, pekdemir h, TOPSAKAL R, ŞAHİNER M, Aras D, Oto A (2019). Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. , 272 - 280. 10.14744/AnatolJCardiol.2019.78178
Chicago	YETİŞ SAYIN Begüm,OKUTUCU Sercan,YILMAZ MEHMET BIRHAN,ÖZDEMİR Kurtuluş,AYDINLAR ALİ,ŞAHİN Durmuş Yıldıray,ALTUN ARMAGAN,AÇIKEL Sadık,OKUYAN ERTUGRUL,Sucu Murat,ÖNGEN Zeki,Ersanli Murat Kazim,YILMAZ Özcan,Demir Mesut,pekdemir hasan,TOPSAKAL Ramazan,ŞAHİNER Mehmet Levent,Aras Dursun,Oto Ali Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. (2019): 272 - 280. 10.14744/AnatolJCardiol.2019.78178
MLA	YETİŞ SAYIN Begüm,OKUTUCU Sercan,YILMAZ MEHMET BIRHAN,ÖZDEMİR Kurtuluş,AYDINLAR ALİ,ŞAHİN Durmuş Yıldıray,ALTUN ARMAGAN,AÇIKEL Sadık,OKUYAN ERTUGRUL,Sucu Murat,ÖNGEN Zeki,Ersanli Murat Kazim,YILMAZ Özcan,Demir Mesut,pekdemir hasan,TOPSAKAL Ramazan,ŞAHİNER Mehmet Levent,Aras Dursun,Oto Ali Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. , 2019, ss.272 - 280. 10.14744/AnatolJCardiol.2019.78178
AMA	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. . 2019; 272 - 280. 10.14744/AnatolJCardiol.2019.78178
Vancouver	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. . 2019; 272 - 280. 10.14744/AnatolJCardiol.2019.78178
IEEE	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A "Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry." , ss.272 - 280, 2019. 10.14744/AnatolJCardiol.2019.78178
ISNAD	YETİŞ SAYIN, Begüm vd. "Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry". (2019), 272-280. https://doi.org/10.14744/AnatolJCardiol.2019.78178

APA	YETİŞ SAYIN B, OKUTUCU S, YILMAZ M, ÖZDEMİR K, AYDINLAR A, ŞAHİN D, ALTUN A, AÇIKEL S, OKUYAN E, Sucu M, ÖNGEN Z, Ersanli M, YILMAZ Ö, Demir M, pekdemir h, TOPSAKAL R, ŞAHİNER M, Aras D, Oto A (2019). Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. The Anatolian Journal of Cardiology, 21(5), 272 - 280. 10.14744/AnatolJCardiol.2019.78178
Chicago	YETİŞ SAYIN Begüm,OKUTUCU Sercan,YILMAZ MEHMET BIRHAN,ÖZDEMİR Kurtuluş,AYDINLAR ALİ,ŞAHİN Durmuş Yıldıray,ALTUN ARMAGAN,AÇIKEL Sadık,OKUYAN ERTUGRUL,Sucu Murat,ÖNGEN Zeki,Ersanli Murat Kazim,YILMAZ Özcan,Demir Mesut,pekdemir hasan,TOPSAKAL Ramazan,ŞAHİNER Mehmet Levent,Aras Dursun,Oto Ali Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. The Anatolian Journal of Cardiology 21, no.5 (2019): 272 - 280. 10.14744/AnatolJCardiol.2019.78178
MLA	YETİŞ SAYIN Begüm,OKUTUCU Sercan,YILMAZ MEHMET BIRHAN,ÖZDEMİR Kurtuluş,AYDINLAR ALİ,ŞAHİN Durmuş Yıldıray,ALTUN ARMAGAN,AÇIKEL Sadık,OKUYAN ERTUGRUL,Sucu Murat,ÖNGEN Zeki,Ersanli Murat Kazim,YILMAZ Özcan,Demir Mesut,pekdemir hasan,TOPSAKAL Ramazan,ŞAHİNER Mehmet Levent,Aras Dursun,Oto Ali Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. The Anatolian Journal of Cardiology, vol.21, no.5, 2019, ss.272 - 280. 10.14744/AnatolJCardiol.2019.78178
AMA	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. The Anatolian Journal of Cardiology. 2019; 21(5): 272 - 280. 10.14744/AnatolJCardiol.2019.78178
Vancouver	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry. The Anatolian Journal of Cardiology. 2019; 21(5): 272 - 280. 10.14744/AnatolJCardiol.2019.78178
IEEE	YETİŞ SAYIN B,OKUTUCU S,YILMAZ M,ÖZDEMİR K,AYDINLAR A,ŞAHİN D,ALTUN A,AÇIKEL S,OKUYAN E,Sucu M,ÖNGEN Z,Ersanli M,YILMAZ Ö,Demir M,pekdemir h,TOPSAKAL R,ŞAHİNER M,Aras D,Oto A "Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry." The Anatolian Journal of Cardiology, 21, ss.272 - 280, 2019. 10.14744/AnatolJCardiol.2019.78178
ISNAD	YETİŞ SAYIN, Begüm vd. "Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in Turkey: Inferences from GARFIELD-AF registry". The Anatolian Journal of Cardiology 21/5 (2019), 272-280. https://doi.org/10.14744/AnatolJCardiol.2019.78178